Shuliweeh Alenezi

720 citations
30 papers · 376 indexed · h-index 10
Topics
COVID-19 and Mental Health (6 papers)Vaccine Coverage and Hesitancy (6 papers)SARS-CoV-2 and COVID-19 Research (4 papers)

In The Last Decade

Shuliweeh Alenezi

27 papers receiving 373 citations

Peers

Shuliweeh Alenezi
Comparison fields: 5 of 70
  • Infectious Diseases 144
  • Health 139
  • Virology 102
  • Molecular Biology 80
  • Clinical Psychology 74
Replace Emily Bold with:
Emily Bold United Kingdom
Chiara Causier United Kingdom
Laura March France
Chenglin Hong United States
Mary Hill United States
Lindsey W. Vilca Peru
Siena Napoleon United States
Victoria L. Fields United States
Lauren Towler United Kingdom
Weijun Xiao China
Shuliweeh Alenezi relative to Emily Bold United Kingdom Emily Bold's profile →
Citations per field
00.5×11.3×
Emily Bold · 1×
Citations per year

Countries citing papers authored by Shuliweeh Alenezi

Since Specialization
Citations

This map shows the geographic impact of Shuliweeh Alenezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuliweeh Alenezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuliweeh Alenezi more than expected).

Fields of papers citing papers by Shuliweeh Alenezi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuliweeh Alenezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuliweeh Alenezi. The network helps show where Shuliweeh Alenezi may publish in the future.

Co-authorship network of co-authors of Shuliweeh Alenezi

This figure shows the co-authorship network connecting the top 25 collaborators of Shuliweeh Alenezi. A scholar is included among the top collaborators of Shuliweeh Alenezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuliweeh Alenezi. Shuliweeh Alenezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 4
6 7
7 53
8 34
9 14
10 9
11 2
12 9
13 12
14 10
15 6
16 50
17 49
18 21
19 42
20 9

About Shuliweeh Alenezi

Shuliweeh Alenezi is a scholar working on Health, Virology and Clinical Psychology, having authored 30 papers that have together received 376 indexed citations. Recurring topics across this work include COVID-19 and Mental Health (6 papers), Vaccine Coverage and Hesitancy (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Virology (102 citations), Health (139 citations) and Modeling and Simulation (47 citations). Shuliweeh Alenezi has collaborated with scholars based in Saudi Arabia, United States and Canada. Frequent co-authors include Mohamad‐Hani Temsah, Ali Alhaboob, Fadi Aljamaan, Mazin Barry, Khalid Alhasan, Jaffar A. Al‐Tawfiq, Rabih Halwani, Ali Alaraj, Fahad Alzamil and Amr Jamal. Their work appears in journals such as Vaccine, Child Abuse & Neglect and Heliyon.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026